We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

112 hedge funds and large institutions have $187M invested in Provention Bio, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more call options, than puts

Call options by funds: $4.45M | Put options by funds: $1.21M

183% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 18

87% more capital invested

Capital invested by funds: $99.9M → $187M (+$87.1M)

3% less funds holding

Funds holding: 115 → 112 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

Holders
112
Holders Change
-3
Holders Change %
-2.61%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
51
Reduced
18
Closed
14
Calls
$4.45M
Puts
$1.21M
Net Calls
+$3.24M
Net Calls Change
+$919K

Top Buyers

Rank Fund Capital Flow
1
SC
Sessa Capital
New York
+$40.5M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$22.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$4.68M
4
BlackRock
BlackRock
New York
+$1.93M
5
PAI
Palo Alto Investors
California
+$1.78M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$617K
2
DCM
DG Capital Management
New York
-$562K
3
Goldman Sachs
Goldman Sachs
New York
-$530K
4
Verition Fund Management
Verition Fund Management
Connecticut
-$425K
5
JF
Jump Financial
Illinois
-$222K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$69K – – –
FA
77
Forefront Analytics
Pennsylvania
$68K -$29.3K -6,430 -30%
Principal Financial Group
78
Principal Financial Group
Iowa
$68K +$697 +153 +1%
ASRS
79
Arizona State Retirement System
Arizona
$67K +$884 +194 +1%
JWCA
80
J.W. Cole Advisors
Florida
$66K +$2.28K +500 +4%
AQR Capital Management
81
AQR Capital Management
Connecticut
$62K +$63.2K +13,864 New
ProShare Advisors
82
ProShare Advisors
Maryland
$61K +$9.49K +2,082 +18%
CG
83
Cutler Group
California
$59K – – –
NFSG
84
Newbridge Financial Services Group
Florida
$59K – – –
WS
85
Wedbush Securities
California
$59K – – –
Wolverine Trading
86
Wolverine Trading
Illinois
$58K +$59.8K +13,114 New
Jane Street
87
Jane Street
New York
$52K +$52.4K +11,504 New
State of Wisconsin Investment Board
88
State of Wisconsin Investment Board
Wisconsin
$46K -$13K -2,852 -22%
CF
89
Cantor Fitzgerald
New York
$45K +$45.6K +10,000 New
AB
90
Amalgamated Bank
New York
$40K +$1.92K +421 +5%
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
$35K +$22.1K +4,854 +167%
DA
92
Denali Advisors
California
$32K – – –
Wells Fargo
93
Wells Fargo
California
$23K -$1.67K -367 -7%
Zurich Cantonal Bank
94
Zurich Cantonal Bank
Switzerland
$22K – – –
DAC
95
Dividend Assets Capital
South Carolina
$18K – – –
MLICM
96
Metropolitan Life Insurance Company (MetLife)
New York
$16.2K +$11.2K +2,447 +214%
AIP
97
Ameritas Investment Partners
Nebraska
$16K – – –
Citigroup
98
Citigroup
New York
$14K -$14.2K -3,120 -50%
Rockefeller Capital Management
99
Rockefeller Capital Management
New York
$13K – – –
Canada Life
100
Canada Life
Manitoba, Canada
$12K – – –
1 2 3
4
5

PRVB Hedge Fund Activity: Q3 2022 in Review

112 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q3 2022, worth a combined $187M — up 87% from $99.9M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of PRVB and 11 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 51 added.

The largest buyer was Sessa Capital, adding an estimated $40.5M. The largest seller was Renaissance Technologies, cutting an estimated $617K.

  • 112 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q3 2022, down from 115 in Q2 2022.
  • Funds reported $187M of Provention Bio, Inc. Common Stock stock for Q3 2022, up 87% quarter-over-quarter.
  • 11 funds opened new Provention Bio, Inc. Common Stock positions in Q3 2022 and 14 closed out, a net change of -3 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q3 2022 was Sessa Capital, an estimated $40.5M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q3 2022 was Renaissance Technologies, an estimated $617K sold.

Based on aggregated 13F filings for Q3 2022.